Modulation of DNA repair genes induced by TLR9 agonists: A strategy to eliminate "altered" cells?

Autor: Sommariva M; Department of Human Morphology and Biomedical Sciences 'Città Studi'; Università degli Studi di Milano; Milan, Italy ; Molecular Targeting Unit Fondazione IRCCS; Istituto Nazionale Tumori; Milan, Italy., De Cecco L, Tagliabue E, Balsari A
Jazyk: angličtina
Zdroj: Oncoimmunology [Oncoimmunology] 2012 Mar 01; Vol. 1 (2), pp. 258-259.
DOI: 10.4161/onci.1.2.18343
Abstrakt: We provided evidence that the TLR9 engagement of innate immune cells present in the tumor microenvironment by CpG-oligodeoxynucleotide (CpG-ODN) induces down-modulation of DNA repair gene expression in tumor cells, sensitizing cancer cells to DNA-damaging chemotherapy. These findings expand the benefits of CpG-ODN therapy beyond induction of a strong immune response.
Databáze: MEDLINE